A Phase II Study of Allogeneic Hematopoietic Stem Cell Transplant for Subjects With VEXAS (Vacuoles, E1 Enzyme, X-linked, Autoinflammatory, Somatic) Syndrome
for Immunodeficiency
1 location in Bethesda
Sponsor: National Cancer Institute (NCI)
Sex: All·Age: 18 - 75
Code: NCT05027945·Phase 2·Recruiting